Kenneth R. Peak Center for Brain and Pituitary Tumor Treatment and Research provides world-class personalized neurosurgical and oncological treatments for patients with brain, spine and pituitary tumors in a compassionate environment geared toward scientific advances, education and research.
Novel Gene Therapy Treatment - Alex's Story
Alex Gross of Myrtle Beach, SC was diagnosed with Glioblastoma at age 16 and was basically given weeks to live. After searching online for additional treatment options, Alex's family found the story of Ed McCumber on YouTube, who also happens to reside in Myrtle Beach. Soon after meeting the Ed in person and learning more about the Peak Center and gene therapy, Alex's family traveled to Houston Methodist Hospital. Over one year later, Alex continues to improve.
Novel Gene Therapy Treatment - Stratton's Story
Stratton Muhmel was diagnosed with Glioblastoma – an aggressive brain tumor with a median survival timeline of 15 months. Refusing to give up, he came to Houston Methodist after learning about an experimental new treatment that may extend survival timelines for Glioblastoma patients.
Surviving and Thriving After Gene Therapy - Stratton's Story
Now, 1 year and 4 months later, Stratton is a 2020 graduate from Texas A&M Galveston.
Learn more about our gene therapy clinical trial at the Peak Center
Treating Glioblastoma With Innovative Gene Therapy - Ed's Story
Ed McCumber’s glioblastoma was so malignant and aggressive, it recurred two times. Left with no options, he turned to neurosurgeon Dr. David Baskin, MD, for help. After removing the tumor, Baskin used a specialized form of gene therapy, invented at Houston Methodist, to attack the remaining cancer cells.
Gene Therapy Re-Treatment - Ed's Story
Today, over 2 years and 3 months later, Ed is the first patient in the world to be re-treated with the experimental gene therapy and he continues to defy the odds.
The Longest Living Survivor At Houston Methodist - Matt's Story
Matt Futer was given less than 3 months to live when he was initially diagnosed with glioblastoma. After successful treatment of the experimental gene therapy, Matt has been cancer free for over 7 years.
Oncomagnetics: A New Experimental Treatment for Brain Cancer
The Peak Center has developed an experimental magnetic device in the form of an easily wearable and removable helmet. It generates concentrated, oscillating frequencies and patterns that have been shown to destroy brain cancer by targeting and disrupting dysfunctional energy production in the cancer cells.
Patients do not have to shave their heads and only 6 hours of treatment time is required per day.
Request more information on this experimental treatment here.
David Baskin, MD Discusses The Benefits Offered At The Peak Center
Learn how the Kenneth R. Peak Brain & Pituitary Tumor Treatment Center combines cutting-edge surgical technology, state-of-the-art research protocols and highly skilled physicians and nurses to provide personalized and compassionate care for patients.
The Peak Center offers cutting-edge scientific analyses of each patient’s tumor, allowing our physicians to design personalized treatment plans based on genetic information, detailed screening of the tumor and other advanced scientific techniques. Treatment options utilize state-of-the-art techniques, including minimally invasive surgery, focused stereotactic radiosurgery and novel technology.
The Center is unique in many ways. Basic science researchers in nanotechnology, gene therapy, biochemistry, neurochemistry, stem cell technology and genetics work side-by-side with world class clinicians, including neurosurgeons, neuro-oncologists, neurologists, radiation oncologists and rehabilitation specialists to provide personalized care for each and every patient. The Center will provide highly personalized care to patients with tumors in ways not previously available anywhere in the world.
The specialists at the Houston Methodist Peak Brain & Pituitary Tumor Center have access to advanced technology to detect, diagnose and treat pituitary adenomas (non-cancerous), pituitary carcinomas (cancerous), and other types of tumors that grow in and around the pituitary gland. Peak Center physicians work collaboratively and seamlessly with specialists from other areas of medicine so patients benefit from the full breadth of Houston Methodist Hospital excellence.
Most pituitary tumors can be treated. Virtually all tumors can be removed surgically or reduced in size with other means, and prognosis for patients is excellent.
The Center houses four programs aimed at providing tumor-specific clinical care and research while fostering interdisciplinary collaboration (multiple medical and surgical specialties).
Houston Methodist Team Saves Man with Gigantic Brain Tumor
The doctors describe it as one of the most complicated cases of their careers. Learn more.
Investigational Magnetic Device Shrinks Glioblastoma in First Test
Researchers shrunk a glioblastoma tumor in a first-in-world human test using a helmet generating a noninvasive magnetic field. Learn more.
Our research is developing novel approaches to fighting cancer, including mitochondrial smart bombs, nanosyringes for efficient drug delivery, drug pump inhibitors to trap chemotherapy in cancer cells, and gene therapy approaches. Learn more
Novel Gene Therapy Shows Early Promise Against Glioblastoma
Early trials of a new form of gene therapy may give hope to patients battling glioblastoma, the most deadly form of brain cancer. Learn more
How do you handle risk?
Houston Methodist's Dr. David Baskin shares how preparation and training can help reduce the impact of the unexpected in a chapter of the new book The Art of Risk.
Pictured here are Kayt Sukel, the book’s author, Dr. Baskin and his daughter.
Experimental glioblastoma therapy shows curative powers in mice models
Houston Methodist researchers found mice harboring human glioblastoma tumors in their brains had greatly enhanced survival when given a newly developed prodrug that targets and destroys the DNA inside the glioblastoma cell mitochondria, leaving normal cells intact. Learn more.